L. Vandekerckhove

European guidelines on the clinical management of HIV-1 tropism testing.

A. Wensing, H. Walter, R. Kaiser, 2011, The Lancet. Infectious diseases.

Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing

H. Walter, R. Kaiser, K. Korn, 2010, Journal of the International AIDS Society.

Concordance between HIV‐1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

L. Vandekerckhove, S. De Wit, A. Geretti, 2011, HIV medicine.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Late presentation to HIV testing is overestimated when based on the consensus definition

M. Van Ranst, A. Pharris, M. Moutschen, 2015, HIV medicine.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

OP 1.7 – 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir

E. van Gulck, L. Vandekerckhove, D. Boden, 2022, Journal of virus eradication.

OP 3.8 – 00066 Characterization of the HIV-1 viral reservoir in subtype B early treated individuals

M. Lichterfeld, L. Vandekerckhove, S. Rutsaert, 2022, Journal of virus eradication.

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

A. Mocroft, A. d’Arminio Monforte, A. Clarke, 2018, HIV medicine.

Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium

J. Martinez-Picado, C. Boucher, L. Vandekerckhove, 2021, Journal of virus eradication.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.